Chad Leep, MD
Family Medicine · Greenville, SCNPI 1073741500
Payments from drug & device makers
Across 54 payments — averaging $17.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$294
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$109
- AstraZeneca$59
- Lilly USA, LLC$53
- Amgen$47
- Novo Nordisk$44
- plus $320 from 15 others
What the payments were for
- Food & beverage$926100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 14 | $294 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $109 |
| AstraZeneca | 4 | $59 |
| Lilly USA, LLC | 4 | $53 |
| Amgen | 3 | $47 |
| Novo Nordisk | 3 | $44 |
| Astellas Pharma US Inc | 2 | $34 |
| Antares Pharma, Inc. | 2 | $33 |
| AbbVie | 2 | $33 |
| Johnson & Johnson | 2 | $31 |
| Vertex | 1 | $26 |
| Hikma Pharmaceuticals USA | 1 | $24 |
| Dexcom, Inc. | 1 | $18 |
| Inari Medical, Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Merck | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Exact Sciences | 1 | $14 |
| GSK | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| GT Medical Technologies, Inc | 1 | $13 |
How this compares
$926 in reported general payments places this provider in the 55th percentile of 2,153 family medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 97 | $695 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 48 | $396 |
| Doxycycline Hyclate | 54 | $377 |
| Fluticasone Propionate | 55 | $350 |
| Trazodone Hcl | 19 | $327 |
| Diclofenac Sodium | 37 | $276 |
| Azithromycin | 74 | $260 |
| Losartan Potassium | 13 | $234 |
| Amlodipine Besylate | 27 | $155 |
| Prednisone | 120 | $142 |
| Verapamil Hcl | 15 | $126 |
| Omeprazole | 14 | $52 |
| Ciprofloxacin Hcl | 13 | $45 |
| Triamcinolone Acetonide | 13 | $37 |
| Pantoprazole Sodium | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Greenville
- James FranklinGreenville$3.5M
- Jeffrey HarrisGreenville$3.4M
- Christopher DavisGreenville$2.7M
- Harlicia FarleyGreenville$1.1M
- James WallaceGreenville$708K
- Eric Garcia-TorresGreenville$102K
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.